Bavarian Nordic News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.11.15	Bavarian Nordic to Present at Jefferies 2015 Global Healthcare Conference in London (GlobeNewswire)
03.11.15	Bavarian Nordic Announces Results of a Phase 1 Trial Investigating Brachyury Specific Cancer Vaccine in Patients with Advanced Cancers (GlobeNewswire)
03.11.15	Bavarian Nordic Announces Interim Results for the First Nine Months of 2015 (GlobeNewswire)
28.10.15	Bavarian Nordic Announces Expansion of IMVAMUNE® Orders from Canadian Government (GlobeNewswire)
27.10.15	Bavarian Nordic to Host Third Quarter 2015 Results Conference Call (GlobeNewswire)
09.10.15	Bavarian Nordic Announces Initiation of Safety and Immunogenicity Study of Ebola Vaccine Regimen in Sierra Leone (GlobeNewswire)
14.09.15	Bavarian Nordic Receives Contract Valued at USD 9 Million from Janssen as part of Advanced Development of Prime-Boost Ebola Vaccine Regimen (GlobeNewswire)
11.09.15	Bavarian Nordic issues Financial Calendar for 2016 (GlobeNewswire)
25.08.15	Bavarian Nordic Announces First Half 2015 Results (GlobeNewswire)
19.08.15	Bavarian Nordic to Host First Half 2015 Results Conference Call (GlobeNewswire)
18.08.15	Bavarian Nordic Initiates Phase 1 Clinical Trial of MVA-BN® in Respiratory Syncitial Virus (RSV) (GlobeNewswire)
24.07.15	Bavarian Nordic Announces Initiation of NCI-sponsored Phase 2 Study of PROSTVAC in Patients with Localized Prostate Cancer (GlobeNewswire)
15.07.15	Bavarian Nordic Announces that the Oxford Vaccines Group has Initiated a Phase 2 Study of the Ebola Prime-Boost Vaccine Regimen Combining MVA-BN® Filo and Janssen's AdVac® Technology (GlobeNewswire)
07.07.15	Bavarian Nordic Receives Order for IMVAMUNE® Smallpox Vaccine from the U.S. Government Valued at USD 133 Million (GlobeNewswire)
30.06.15	Bavarian Nordic Announces Option Exercise by U.S. Government for Development of Filovirus Vaccine (GlobeNewswire)
28.05.15	Bavarian Nordic to Present at Jefferies 2015 Global Healthcare Conference in New York (GlobeNewswire)
21.05.15	Members of the management and the board increase their share holdings in Bavarian Nordic A/S (GlobeNewswire)
18.05.15	Bavarian Nordic A/S Issues New Shares in Connection with Exercise of Warrants (GlobeNewswire)
13.05.15	Bavarian Nordic Announces Positive Results from Two Pivotal Clinical Studies of IMVAMUNE® Smallpox Vaccine (GlobeNewswire)
12.05.15	Bavarian Nordic Announces Presentation of Preliminary Phase 1 Results for the Ebola Prime-Boost Vaccine Regimen of MVA-BN® Filo and Janssen's AdVac® technology (GlobeNewswire)
12.05.15	Bavarian Nordic Granted EUR 50 Million Loan from The European Investment Bank (GlobeNewswire)
05.05.15	Bavarian Nordic Announces Interim Results for the First Three Months of 2015 (GlobeNewswire)
23.04.15	Bavarian Nordic A/S - Report on the Results of the Annual General Meeting, held 23 April 2015 (GlobeNewswire)
14.04.15	Bavarian Nordic to Present at Needham & Company's 14th Annual Healthcare Conference in New York City (GlobeNewswire)
27.03.15	Bavarian Nordic A/S - Notice Convening Ordinary General Meeting (GlobeNewswire)
13.03.15	Bavarian Nordic A/S - Major Shareholder Announcement (GlobeNewswire)
11.03.15	Bavarian Nordic Announces 2014 Full Year Results (GlobeNewswire)
04.03.15	Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC®, a Prostate-Specific Antigen-Targeting Cancer Immunotherapy (GlobeNewswire)
24.02.15	Bavarian Nordic Announces Updated Overall Survival Data from Combination Immunotherapy Data of PROSTVAC plus Ipilimumab at the 2015 Genitourinary Cancers Symposium (GlobeNewswire)
27.01.15	Bavarian Nordic A/S - Major Shareholder Announcement (GlobeNewswire)
06.01.15	Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial for the Ebola Vaccine Regimen of MVA-BN® Filo and Janssen's AdVac® technology (GlobeNewswire)
10.12.14	Bavarian Nordic Reaches Enrollment Target in the Pivotal Phase 3 Study of PROSTVAC® in Prostate Cancer (GlobeNewswire)
04.12.14	Bavarian Nordic Announces First Subject Dosed with MVA-BN® Filo in a Phase 1 Study Investigating a New Prime-Boost Regimen of Ebola Candidate Vaccines (GlobeNewswire)
18.11.14	Bavarian Nordic A/S Issues New Shares in Connection with Exercise of Warrants (GlobeNewswire)
13.11.14	Bavarian Nordic Announces Interim Results for the First Nine Months of 2014 (GlobeNewswire)
06.11.14	Bavarian Nordic to Host Third Quarter 2014 Results Conference Call (GlobeNewswire)
29.10.14	Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation (GlobeNewswire)
22.10.14	Bavarian Nordic Announces Expanded Collaboration with Janssen on MVA-BN® for Additional Infectious Disease Targets (GlobeNewswire)
22.10.14	Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation (GlobeNewswire)
22.10.14	Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation (GlobeNewswire)
22.10.14	Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine (GlobeNewswire)
04.09.14	Bavarian Nordic Announces Exercise of Contract Option by the U.S. Government for Continued Supply of IMVAMUNE® Smallpox Vaccine (GlobeNewswire)
04.09.14	Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health (GlobeNewswire)
28.08.14	Bavarian Nordic Announces First Half 2014 Results (GlobeNewswire)
26.08.14	Bavarian Nordic Receives Order from the Canadian Government to Supply IMVAMUNE® Smallpox Vaccine (GlobeNewswire)
24.06.14	Bavarian Nordic to Participate in European Midcap Event in Paris (GlobeNewswire)
04.06.14	Bavarian Nordic to Present at Jefferies 2014 Global Healthcare Conference in New York (GlobeNewswire)
28.05.14	Bavarian Nordic Announces Appointment of Paul Chaplin, Ph.D. as President & CEO (GlobeNewswire)
27.05.14	Bavarian Nordic A/S Issues New Shares in Connection with Exercise of Warrants (GlobeNewswire)
15.05.14	Bavarian Nordic to Present Data Combining its Cancer Immunotherapies with Immune Checkpoint Inhibitors at the 2014 ASCO Annual Meeting (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

22.08.24		Bavarian Nordic-Aktie im Rally-Modus: Bavarian Nordic übertrifft Erwartungen um Längen
22.08.24		Ausblick: Bavarian Nordic legt Quartalsergebnis vor
20.08.24		Bavarian Nordic-Aktie dreht ins Minus: Produktion von Mpox-Impfstoff wird gesteigert - Halbjahreszahlen stehen an
23.08.22		Ausblick: Bavarian Nordic gewährt Anlegern Blick in die Bücher

22.08.24

Bavarian Nordic-Aktie im Rally-Modus: Bavarian Nordic übertrifft Erwartungen um Längen

22.08.24

Ausblick: Bavarian Nordic legt Quartalsergebnis vor

20.08.24

Bavarian Nordic-Aktie dreht ins Minus: Produktion von Mpox-Impfstoff wird gesteigert - Halbjahreszahlen stehen an

23.08.22

Ausblick: Bavarian Nordic gewährt Anlegern Blick in die Bücher

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Bavarian Nordic A/S

Aktien Top/Flop

Bavarian Nordic Peer Group Nachrichten

Meistgelesene Nachrichten